View More Recent Stories

Jul 8, 2024 08:35AM Outlook Therapeutics (OTLK) Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
View More Recent Stories